SC
ZY

Sculptor Capital’s Zymergen Inc. Common Stock ZY Stock Holding History

Sculptor Capital’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-53,000
Closed -$698K – 1327
2021
Q3 		$698K Buy
+53,000
New +$1.12M 0.01% 619

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

Sculptor Capital's ZY Position: Q4 2021 in Review

Sculptor Capital sold out of Zymergen Inc. Common Stock (ZY) in Q4 2021, closing a stake of 53,000 shares — an estimated $698K sold.

Sculptor Capital first reported a position in ZY in Q3 2021 and held it in 1 quarter. The position peaked at $698K in Q3 2021. 91 funds tracked by Wall St. Rank hold ZY as of Q4 2021.

  • Sculptor Capital reported no remaining Zymergen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Sculptor Capital sold 53,000 Zymergen Inc. Common Stock shares in Q4 2021, an estimated $698K.
  • Sculptor Capital first reported a position in Zymergen Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Sculptor Capital's Zymergen Inc. Common Stock position peaked at $698K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2021.

Based on Sculptor Capital's 13F filing for Q4 2021, filed 11 Feb 2022.